The association of the Val66Met (rs6265) polymorphism in the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder (BD) and response to lithium treatment has been suggested, though inconsistently. The considerable diversity of allele frequency across different populations contributes to this. There is no data from South Asia till date. Hence, we examined the association of this polymorphism in BD cases from India, and its association with lithium treatment response.
Methods:
BD patients (N = 301) were recruited from the clinical services of National Institute of Mental Health and Neurosciences (NIMHANS), India. Lithium treatment response for 190 BD subjects was assessed using Alda scale by NIMH life charts. Patients with total score ⩾7 were defined as lithium responders (N = 115) and patients with score <7 were defined as lithium non-responders (N = 75). Healthy controls (N = 484) with no lifetime history of neuropsychiatric illness or a family history of mental illness were recruited as control set. Genotyping was performed by TaqMan genotyping assay.
Results:
Genotype and allele frequency of BDNF Val66Met SNP was significantly different (χ2 = 7.78, p = 0.02) in cases compared to controls, and the Val(G) allele was more frequent (χ2 = 7.08, p = 0.008) in BD patients. However, no significant difference is noted in genotype or allele frequencies of this polymorphism between the lithium responders and non-responders.
Conclusions:
The Val(G) allele of BDNF Val66Met polymorphism is associated with risk of BD in this sample, but it is not related to response to lithium.
American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 4th edn. Text revision. Washington, DC: Author.
2.
BathinaSDasUN (2015) Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci11: 1164–1178. DOI: 10.5114/aoms.2015.56342.
3.
BerkolTDİslamSKırlıE, et al. (2016) Suicide attempts and clinical features of bipolar patients. Saudi Med J37: 662–667. DOI: 10.15537/smj.2016.6.12776.
4.
BjörkholmCMonteggiaLM (2016) BDNF – A key transducer of antidepressant effects. Neuropharmacology102: 72–79. DOI: 10.1016/j.neuropharm.2015.10.034.
5.
CarrardASalzmannAPerroudN, et al. (2011) Genetic association of the phosphoinositide-3 kinase in schizophrenia and bipolar disorder and interaction with a BDNF gene polymorphism. Brain Behav1: 119–124. DOI: 10.1002/brb3.23.
6.
ChangS-HGaoLLiZ, et al. (2013a) BDgene: A genetic database for bipolar disorder and its overlap with schizophrenia and major depressive disorder. Biol Psychiatry74: 727–733. DOI: 10.1016/J.BIOPSYCH.2013.04.016.
7.
ChangYHLeeSYChenSL, et al. (2013b) Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder. J Affect Disord151: 967–972. DOI: 10.1016/j.jad.2013.08.017.
8.
CichonSMühleisenTWDegenhardtFA, et al. (2011) Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet88: 372–381. DOI: 10.1016/j.ajhg.2011.01.017.
9.
De LucaVStraussJSemeralulM, et al. (2008) Analysis of BDNF Val66Met allele-specific mRNA levels in bipolar disorder. Neurosci Lett441: 229–232. DOI: 10.1016/j.neulet.2008.06.025.
10.
Dmitrzak-WeglarzMRybakowskiJKSuwalskaA, et al. (2008) Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients. Pharmacogenomics9: 1595–1603. DOI: 10.2217/14622416.9.11.1595.
11.
EscamillaMAZavalaJM (2008) Genetics of bipolar disorder. Dialogues Clin Neurosci10: 141–152.
12.
FernandesBSMolendijkMLKöhlerCA, et al. (2015) Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: A meta-analysis of 52 studies Brisa. BMC Med13: 289. DOI: 10.1186/s12916-015-0529-7.
13.
FrazierTWYoungstromEAFrankelBA, et al. (2014) Candidate gene associations with mood disorder, cognitive vulnerability, and fronto-limbic volumes. Brain Behav4: 418–430. DOI: 10.1002/brb3.226.
14.
González-CastroTBNicoliniHLanzagortaN, et al. (2015) The role of brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism in bipolar disorder: a case-control study, comorbidities, and meta-analysis of 16,786 subjects. Bipolar Disord17: 27–38. DOI: 10.1111/bdi.12227.
15.
GordovezFJAMcMahonFJ (2020) The genetics of bipolar disorder. Mol Psychiatry25: 544–559. DOI: 10.1038/s41380-019-0634-7.
16.
GrandeIBerkMBirmaherB, et al. (2016) Bipolar disorder. Lancet387: 1561–1572. DOI: 10.1016/S0140-6736(15)00241-X.
17.
GreenEKRaybouldRMacgregorS, et al. (2006) Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: Case-control study of over 3000 individuals from the UK. Br J Psychiatry188: 21–25. DOI: 10.1192/bjp.bp.105.009969.
18.
HouLHeilbronnerUDegenhardtF, et al. (2016) Genetic variants associated with response to lithium treatment in bipolar disorder: A genome-wide association study. Lancet387: 1085–1093. DOI: 10.1016/S0140-6736(16)00143-4.
19.
IvanovaMAChristovaTNAsanTS, et al. (2013) Evidence of an association between bipolar disorder and rs16917237 in the BDNF gene in a Bulgarian sample. Psychiatr Genet23(3): 141–142. DOI: 10.1097/YPG.0b013e32835d7225.
20.
JohnsonJLAbecasisGR (2017) GAS Power Calculator: Web-based power calculator for genetic association studies. bioRxiv. DOI: 10.1101/164343.
21.
KapurVNadellaRKSathur RaghuramanB, et al. (2019) Clinical factors associated with lithium treatment response in bipolar disorder patients from India. Asian J Psychiatr39: 165–168. DOI: 10.1016/j.ajp.2018.04.006.
KharePRajVChandraS, et al. (2014) Quantitative and qualitative assessment of DNA extracted from saliva for its use in forensic identification. J Forensic Dent Sci6: 81–85. DOI: 10.4103/0975-1475.132529.
24.
KimBKimCYHongJP, et al. (2008) Brain-derived neurotrophic factor Val/Met polymorphism and bipolar disorder: Association of the met allele with suicidal behavior of bipolar patients. Neuropsychobiology58: 97–103. DOI: 10.1159/000162356.
25.
KohliMALucaeSSaemannPG, et al. (2011) The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron70: 252–265. DOI: 10.1016/j.neuron.2011.04.005.
26.
KunugiHIijimaYTatsumiM, et al. (2004) No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: A multicenter study. Biol Psychiatry56: 376–378. DOI: 10.1016/j.biopsych.2004.06.017.
27.
LangUEHellwegRSanderT, et al. (2009) The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol Psychiatry14: 120–122. DOI: 10.1038/mp.2008.80.
28.
LiMChangHXiaoX (2016) BDNF Val66Met polymorphism and bipolar disorder in European populations: A risk association in case-control, family-based and GWAS studies. Neurosci Biobehav Rev68: 218–233. DOI: 10.1016/j.neubiorev.2016.05.031.
29.
LinC-CLeeC-TLoY-T, et al. (2016) Brain-derived neurotrophic factor protein and mRNA levels in patients with bipolar mania – A preliminary study. Biomed J39: 272–276. DOI: 10.1016/J.BJ.2016.08.001.
30.
LiuMLingSHLiWB, et al. (2007) An association study between GRIN1, BDNF genes and bipolar disorder. Yi Chuan29: 41–46. DOI: 10.1360/yc-007-0041.
31.
LohoffFWSanderTFerraroTN, et al. (2005) Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet139B: 51–53. DOI: 10.1002/ajmg.b.30215.
32.
Machado-VieiraR (2018) Lithium, stress, and resilience in bipolar disorder: Deciphering this key homeostatic synaptic plasticity regulator. J Affect Disord233: 92–99. DOI: 10.1016/j.jad.2017.12.026.
33.
McMahonFJAkulaNSchulzeTG, et al. (2010) Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat Genet42: 128–131. DOI: 10.1038/ng.523.
34.
ManchiaMAdliMAkulaN, et al. (2013) Assessment of response to lithium maintenance treatment in bipolar disorder: A Consortium on Lithium Genetics (ConLiGen) report. PLoS One8: e65636. DOI: 10.1371/journal.pone.0065636.
35.
MandoliniGMLazzarettiMPigoniA, et al. (2019) The impact of BDNF Val66Met polymorphism on cognition in bipolar disorder: A review. J Affect Disord243: 552–558. DOI: 10.1016/j.jad.2018.07.054.
36.
MasuiTHashimotoRKusumiI, et al. (2006) Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder. Psychiatr Genet16: 49–50. DOI: 10.1097/01.ypg.0000180680.72922.57.
37.
MerikangasKRJinRHeJ-P, et al. (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry68: 241–251. DOI: 10.1001/archgenpsychiatry.2011.12.
38.
MichelonLMeira-LimaICordeiroQ, et al. (2006) Association study of the INPP1, 5HTT, BDNF, AP-2β and GSK-3β GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder. Neurosci Lett403: 288–293. DOI: 10.1016/j.neulet.2006.05.001.
39.
MillerSADykesDDPoleskyHF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res16: 1215.
40.
MinHJChoHSKimSJ, et al. (2012) Association of the brain-derived neurotrophic factor gene and clinical features of bipolar disorder in Korea. Clin Psychopharmacol Neurosci10: 163–167. DOI: 10.9758/cpn.2012.10.3.163.
41.
MoreiraFPFabiãoJDBittencourtG, et al. (2015) The Met allele of BDNF Val66Met polymorphism is associated with increased BDNF levels in generalized anxiety disorder. Psychiatr Genet25: 201–207. DOI: 10.1097/YPG.0000000000000097.
42.
MühleisenTWLeberMSchulzeTG, et al. (2014) Genome-wide association study reveals two new risk loci for bipolar disorder. Nat Commun5: 3339. DOI: 10.1038/ncomms4339.
43.
MunkholmKVinbergMKessingLV (2016) Peripheral blood brain-derived neurotrophic factor in bipolar disorder: A comprehensive systematic review and meta-analysis. Mol Psychiatry21: 216–228. DOI: 10.1038/mp.2015.54.
44.
NakataKUjikeHSakaiA, et al. (2003) Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett337: 17–20. DOI: 10.1016/S0304-3940(02)01292-2.
45.
NassanMCroarkinPELubyJL, et al. (2015) Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorder HHS Public Access. Bipolar Disord17: 645–652. DOI: 10.1111/bdi.12323.
46.
Neves-PereiraMCheungJKPasdarA, et al. (2005) BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry10: 208–212. DOI: 10.1038/sj.mp.4001575.
47.
OswaldPDel-FaveroJMassatI, et al. (2004) Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: A Belgian patient-control study. Am J Med Genet B Neuropsychiatr Genet129B: 34–35. DOI: 10.1002/ajmg.b.30056.
48.
PaeCUChiesaAPorcelliS, et al. (2012) Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Neuropsychobiology65: 1–11. DOI: 10.1159/000327605.
49.
PaganiRGaspariniAIelminiM, et al. (2019) Twenty years of Lithium pharmacogenetics: A systematic review. Psychiatry Res278: 42–50. DOI: 10.1016/j.psychres.2019.05.036.
50.
ParkCKimJNamgungE, et al. (2017) The BDNF Val66Met polymorphism affects the vulnerability of the brain structural network. Front Hum Neurosci11: 400. DOI: 10.3389/fnhum.2017.00400.
51.
PisanuCSquassinaAAldaM, et al. (2020) Pharmacogenomics of bipolar disorder. In: BauneBT (ed.) Personalized Psychiatry. San Diego: Academic Press, pp.393–402. DOI: 10.1016/B978-0-12-813176-3.00032-8.
52.
RaiVJamalFKumarP (2019) Brain derived neurotrophic factor (BDNF) Val66Met polymorphism is not risk factor for bipolar disorder. medRxiv. DOI: 10.1101/19010280.
53.
RakofskyJJResslerKJDunlopBW (2012) BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity. Mol Psychiatry17(1): 22–35. DOI: 10.1038/mp.2011.121.
54.
RodriguezSGauntTRDayINM (2009) Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol169: 505–514. DOI: 10.1093/aje/kwn359.
55.
Roy-ByrnePPostRMUhdeTW, et al. (1985) The longitudinal course of recurrent affective illness: Life chart data from research patients at the NIMH. Acta Psychiatr Scand Suppl317: 1–34.
56.
RybakowskiJKCzerskiPDmitrzak-WeglarzM, et al. (2012) Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy. J Psychopharmacol26: 368–373. DOI: 10.1177/0269881111415736.
57.
RybakowskiJKSuwalskaASkibinskaM, et al. (2007) Response to lithium prophylaxis: Interaction between serotonin transporter andBDNF genes. Am J Med Genet B Neuropsychiatr Genet144B: 820–823. DOI: 10.1002/ajmg.b.30420.
58.
ScainiGValvassoriSSDiazAP, et al. (2020) Neurobiology of bipolar disorders: A review of genetic components, signaling pathways, biochemical changes, and neuroimaging findings. Braz J Psychiatry42: 536–551. DOI: 10.1590/1516-4446-2019-0732.
59.
SchulzeTGAldaMAdliM, et al. (2010) The International Consortium on Lithium Genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology62: 72–78. DOI: 10.1159/000314708.
60.
SchumacherJJamraRABeckerT, et al. (2005) Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry58: 307–314. DOI: 10.1016/j.biopsych.2005.04.006.
61.
ShenTYouYJosephC, et al. (2018) BDNF polymorphism: A review of its diagnostic and clinical relevance in neurodegenerative disorders. Aging Dis9: 523–536. DOI: 10.14336/AD.2017.0717.
62.
SigitovaEFišarZHroudováJ, et al. (2017) Biological hypotheses and biomarkers of bipolar disorder. Psychiatry Clin Neurosci71: 77–103. DOI: 10.1111/pcn.12476.
63.
SkibinskaMHauserJCzerskiPM, et al. (2004) Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder. World J Biol Psychiatry5: 215–220. DOI: 10.1080/15622970410029936.
64.
SklarPRipkeSScottLJ, et al. (2011) Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet43: 977–83. DOI: 10.1038/ng.943.
65.
Taj M JRJGaneshSShuklaT, et al. (2018) BDNF gene and obsessive compulsive disorder risk, symptom dimensions and treatment response. Asian J Psychiatr38: 65–69. DOI: 10.1016/j.ajp.2017.10.014.
66.
TangJXiaoLShuC, et al. (2008) Association of the brain-derived neurotrophic factor gene and bipolar disorder with early age of onset in mainland China. Neurosci Lett433: 98–102. DOI: 10.1016/j.neulet.2008.01.001.
67.
TimothyA (2017) An exploratory study of epigenetic changes associated with childhood adversity in children of alcoholics (unpublished data). Doctoral Thesis, National Institute of Mental Health And Neuro Sciences (An Institute of National Importance), Bangalore.
68.
TramontinaJFreyBNAndreazzaAC, et al. (2007) Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder. Mol Psychiatry12: 230–231. DOI: 10.1038/sj.mp.4001941.
69.
TsaiSJ (2018) Critical issues in BDNF Val66met genetic studies of neuropsychiatric disorders. Front Mol Neurosci11: 156. DOI: 10.3389/fnmol.2018.00156.
70.
VinczeIPerroudNBuresiC, et al. (2008) Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene. Bipolar Disord10: 580–587. DOI: 10.1111/j.1399-5618.2008.00603.x.
71.
WangZLiZChenJ, et al. (2012) Association of BDNF gene polymorphism with bipolar disorders in Han Chinese population. Genes Brain Behav11: 524–528. DOI: 10.1111/j.1601-183X.2012.00797.x.
72.
WangZZhangCHuangJ, et al. (2014) MiRNA-206 and BDNF genes interacted in bipolar I disorder. J Affect Disord162: 116–119. DOI: 10.1016/j.jad.2014.03.047.
73.
XuJLiuYWangP, et al. (2010) Positive association between the brain-derived neurotrophic factor (BDNF) gene and bipolar disorder in the Han Chinese population. Am J Med Genet B Neuropsychiatr Genet153B: 275–279. DOI: 10.1002/ajmg.b.30953.
74.
YeCYXuYQHuH, et al. (2009) An association study of brain-derived neurotrophic factor gene polymorphism in bipolar disorders. Natl Med J China89: 1897–1901. DOI: 10.3760/cma.j.issn.0376-2491.2009.27.007.
75.
YosifovaAMushirodaTStoianovD, et al. (2009) Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population. J Affect Disord117(1–2): 87–97. DOI: 10.1016/j.jad.2008.12.021.
